GLS and lymphoma: Researchers have found that c-Myc increases GLS expression through transcriptionally inhibiting miR-23a/b of the GLS 3′ untranslated region, leading to a greater expression of its target protein mitochondrial glutaminase in human lymphoma cells and PCa cells [135].